Idioma:

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Healey, Jeff S. ; Lopes, Renato D. ; Granger, Christopher B. ; Alings, Marco ; Rivard, Lena ; McIntyre, William F. ; Atar, Dan ; Birnie, David H. ; Boriani, Giuseppe ; Camm, A. John ; Conen, David ; Erath, Julia W. ; Gold, Michael R. ; Hohnloser, Stefan H. ; Ip, John ; Kautzner, Josef ; Kutyifa, Valentina ; Linde, Cecilia ; Mabo, Philippe ; Mairesse, Georges ; Benezet Mazuecos, Juan ; Cosedis Nielsen, Jens ; Philippon, Francois ; Proietti, Marco ; Sticherling, Christian ; Wong, Jorge A. ; Wright, David J. ; Zarraga, Ignatius G. ; Coutts, Shelagh B. ; Kaplan, Andrew ; Pombo, Marta ; Ayala-Paredes, Felix ; Xu, Lizhen ; Simek, Kim ; Nevills, Sandra ; Mian, Rajibul ; Connolly, Stuart J.

The New England journal of medicine, 2024-01, Vol.390 (2), p.107-117 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Autor: Healey, Jeff S. ; Lopes, Renato D. ; Granger, Christopher B. ; Alings, Marco ; Rivard, Lena ; McIntyre, William F. ; Atar, Dan ; Birnie, David H. ; Boriani, Giuseppe ; Camm, A. John ; Conen, David ; Erath, Julia W. ; Gold, Michael R. ; Hohnloser, Stefan H. ; Ip, John ; Kautzner, Josef ; Kutyifa, Valentina ; Linde, Cecilia ; Mabo, Philippe ; Mairesse, Georges ; Benezet Mazuecos, Juan ; Cosedis Nielsen, Jens ; Philippon, Francois ; Proietti, Marco ; Sticherling, Christian ; Wong, Jorge A. ; Wright, David J. ; Zarraga, Ignatius G. ; Coutts, Shelagh B. ; Kaplan, Andrew ; Pombo, Marta ; Ayala-Paredes, Felix ; Xu, Lizhen ; Simek, Kim ; Nevills, Sandra ; Mian, Rajibul ; Connolly, Stuart J.
Assuntos: Aged ; Aged, 80 and over ; Anticoagulants ; Anticoagulants - adverse effects ; Anticoagulants - therapeutic use ; Anticoagulation ; Arrhythmias ; Aspirin ; Aspirin - adverse effects ; Aspirin - therapeutic use ; Asymptomatic ; Atrial Fibrillation - complications ; Atrial Fibrillation - diagnosis ; Bleeding ; Canada ; Cardiac arrhythmia ; Cardiology ; Clinical trials ; Coagulation ; Creatinine ; Defibrillators ; Double-Blind Method ; Drug dosages ; Embolism ; Embolism - etiology ; Embolism - prevention & control ; Embolisms ; Factor Xa Inhibitors - adverse effects ; Factor Xa Inhibitors - therapeutic use ; Female ; Fibrillation ; Hematology ; Hemorrhage - chemically induced ; Humans ; Ischemia ; Male ; Medical research ; Medicin och hälsovetenskap ; Monitoring systems ; Neurology ; Neurosurgery ; Oncology ; Pacemakers ; Patients ; Pyridones - adverse effects ; Statistical analysis ; Stroke ; Stroke - etiology ; Stroke - prevention & control ; Thromboembolism ; Treatment Outcome
É parte de: The New England journal of medicine, 2024-01, Vol.390 (2), p.107-117
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
Descrição: In a randomized trial involving patients with subclinical (typically asymptomatic) atrial fibrillation, apixaban led to a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding.
Editor: United States: Massachusetts Medical Society
Idioma: Inglês;Norueguês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

United States: Massachusetts Medical Society

Buscando em bases de dados remotas. Favor aguardar.